Regent Investment Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-42,473
| Closed | -$4.22M | – | 217 |
|
|
2019
Q3 | $4.22M | Sell |
42,473
-50
| -0.1% | -$4.75K | 1.38% | 16 |
|
|
2019
Q2 | $3.93M | Sell |
42,523
-600
| -1% | -$57K | 1.28% | 18 |
|
|
2019
Q1 | $4.07M | Buy |
43,123
+1,045
| +2% | +$91.4K | 1.35% | 16 |
|
|
2018
Q4 | $2.7M | Sell |
42,078
-1,940
| -4% | -$143K | 1.01% | 26 |
|
|
2018
Q3 | $3.94M | Sell |
44,018
-4,895
| -10% | -$433K | 1.23% | 19 |
|
|
2018
Q2 | $3.88M | Sell |
48,913
-980
| -2% | -$81.4K | 1.3% | 17 |
|
|
2018
Q1 | $4.45M | Sell |
49,893
-170
| -0.3% | -$16.3K | 1.51% | 15 |
|
|
2017
Q4 | $5.22M | Sell |
50,063
-4,431
| -8% | -$500K | 1.71% | 12 |
|
|
2017
Q3 | $7.95M | Buy |
54,494
+2,210
| +4% | +$301K | 2.68% | 4 |
|
|
2017
Q2 | $6.79M | Buy |
52,284
+7,095
| +16% | +$869K | 2.39% | 5 |
|
|
2017
Q1 | $5.62M | Buy |
45,189
+4,685
| +12% | +$561K | 2.12% | 8 |
|
|
2016
Q4 | $4.69M | Sell |
40,504
-820
| -2% | -$91.3K | 2.4% | 7 |
|
|
2016
Q3 | $4.32M | Buy |
41,324
+275
| +0.7% | +$29.8K | 2.24% | 8 |
|
|
2016
Q2 | $4.05M | Sell |
41,049
-510
| -1% | -$52.8K | 2.2% | 8 |
|
|
2016
Q1 | $4.16M | Sell |
41,559
-245
| -0.6% | -$25.2K | 2.31% | 7 |
|
|
2015
Q4 | $5.01M | Sell |
41,804
-230
| -0.5% | -$26.6K | 2.68% | 5 |
|
|
2015
Q3 | $4.55M | Buy |
42,034
+1,560
| +4% | +$194K | 2.51% | 6 |
|
|
2015
Q2 | $4.68M | Buy |
40,474
+2,450
| +6% | +$280K | 2.36% | 8 |
|
|
2015
Q1 | $4.38M | Buy |
38,024
+2,740
| +8% | +$327K | 2.22% | 6 |
|
|
2014
Q4 | $3.95M | Sell |
35,284
-125
| -0.4% | -$13.2K | 2.03% | 10 |
|
|
2014
Q3 | $3.36M | Buy |
35,409
+1,945
| +6% | +$176K | 1.72% | 12 |
|
|
2014
Q2 | $2.87M | Buy |
33,464
+2,760
| +9% | +$210K | 1.42% | 17 |
|
|
2014
Q1 | $2.14M | Buy |
30,704
+8,640
| +39% | +$684K | 1.13% | 24 |
|
|
2013
Q4 | $1.86M | Buy |
22,064
+3,270
| +17% | +$259K | 1.05% | 30 |
|
|
2013
Q3 | $1.45M | Sell |
18,794
-1,246
| -6% | -$87.3K | 0.96% | 33 |
|
|
2013
Q2 | $1.17M | Buy |
+20,040
| New | +$1.21M | 0.9% | 36 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Regent Investment Management's CELG Position: Q4 2019 in Review
Regent Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 42,473 shares — an estimated $4.22M sold.
Regent Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.95M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Regent Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Regent Investment Management sold 42,473 Celgene Corp shares in Q4 2019, an estimated $4.22M.
- Regent Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Regent Investment Management's Celgene Corp position peaked at $7.95M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Regent Investment Management's 13F filing for Q4 2019, filed 30 Jan 2020.